| 依那西普治疗风湿性疾病的研究进展 |
| |
| 引用本文： | 夏光涛,王霞,孙红胜,张源潮.依那西普治疗风湿性疾病的研究进展[J].世界临床药物,2014(9):513-518. |
| |
| 作者姓名： | 夏光涛 王霞 孙红胜 张源潮 |
| |
| 作者单位： | 山东大学附属省立医院风湿免疫科,济南250021 |
| |
| 摘 要： | 重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白依那西普为肿瘤坏死因子-α（TNF-α）拮抗剂,可用于多种风湿性疾病的治疗。本文综述依那西普在临床强直性脊柱炎和类风湿关节炎治疗中的研究进展。
|
| 关 键 词： | 依那西普 类风湿关节炎 强直性脊柱炎 |
Advances in the treatment of rheumatic diseases with etanercept |
| |
| XIA Guang-tao,WANG Xia,SUN Hong-sheng,ZHANG Yuan-chao.Advances in the treatment of rheumatic diseases with etanercept[J].WORLD CLINICAL DRUGS,2014(9):513-518. |
| |
| Authors: | XIA Guang-tao WANG Xia SUN Hong-sheng ZHANG Yuan-chao |
| |
| Institution: | (Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji＇nan 250021, China) |
| |
| Abstract: | As a tumor necrosis factor-α （TNF-α） antagonist etanercept has been widely used in the treatment of rheumatic diseases. This review describes the latest research progress of etanercept in ankylosing spondylitis and rheumatoid arthritis in clinic. |
| |
| Keywords: | etanercept rheumatoid arthritis ankylosing spondylitis |
| 本文献已被 维普 等数据库收录！ |
|
